|
|
skeletal system development
|
GO:0001501 |
356 |
0.885
|
Mouse |
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.862
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.861
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.832
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.832
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.819
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.797
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.762
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.721
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.715
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.680
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.650
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.636
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.611
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.609
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.589
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.520
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.516
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.513
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.512
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.512
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.469
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.453
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.446
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.434
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.433
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.432
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.428
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.422
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.387
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.375
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.367
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.350
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.344
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.327
|
Zebrafish |
|
|
response to growth factor
|
GO:0070848 |
198 |
0.323
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.320
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.319
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.307
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.303
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.302
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.298
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.291
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.285
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.282
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.279
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.276
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.269
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.268
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.266
|
|
|
|
regulation of toll signaling pathway
|
GO:0008592 |
1 |
0.258
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.253
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.248
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.245
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.243
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.242
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.229
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.226
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.225
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.219
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.215
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.209
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.208
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.208
|
|
|
|
cartilage condensation
|
GO:0001502 |
18 |
0.205
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.198
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.197
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.191
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.190
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.183
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.182
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.182
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.180
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.179
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.176
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.175
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.175
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.173
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.172
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.172
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.169
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.165
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.161
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.156
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.156
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.155
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.152
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.151
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.151
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.148
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.144
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.144
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.140
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.140
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.136
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.136
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.134
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.133
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.131
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.131
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.129
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.129
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.128
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.127
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.127
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.127
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.124
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.123
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.121
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.118
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.118
|
|
|
|
connective tissue replacement involved in inflammatory response wound healing
|
GO:0002248 |
3 |
0.117
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.115
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.115
|
Mouse |
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.114
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.113
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.111
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.111
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.111
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.108
|
|
|
|
positive regulation of ras protein signal transduction
|
GO:0046579 |
13 |
0.107
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.106
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.106
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.105
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.102
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.101
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.100
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.099
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.098
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.098
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.097
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.096
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.096
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.096
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.096
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.095
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.095
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.093
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.093
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.092
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.091
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.090
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.089
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.089
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.087
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.087
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.085
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.085
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.083
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.083
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.082
|
|
|
|
epithelial cell differentiation involved in mammary gland alveolus development
|
GO:0061030 |
4 |
0.082
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.081
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.081
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.079
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.079
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.078
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.078
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.078
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.078
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.078
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.077
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.077
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.076
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.076
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.076
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.076
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.076
|
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.075
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.074
|
|
|
|
otic vesicle development
|
GO:0071599 |
14 |
0.074
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.072
|
|
|
|
mesenchymal epithelial cell signaling
|
GO:0060638 |
9 |
0.072
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.072
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.071
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.071
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.071
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.070
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.070
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.070
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.069
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.069
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.068
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.068
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.067
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.067
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.067
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.067
|
|
|
|
cell aggregation
|
GO:0098743 |
18 |
0.066
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.066
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.066
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.066
|
|
|
|
otic vesicle morphogenesis
|
GO:0071600 |
10 |
0.066
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.066
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.065
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.064
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.064
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.063
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.063
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.063
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.062
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.062
|
|
|
|
cellular response to vitamin
|
GO:0071295 |
2 |
0.062
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.062
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.061
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.061
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.061
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.060
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.060
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.060
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.060
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.059
|
|
|
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
21 |
0.059
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.058
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.058
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.058
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.058
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.058
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.058
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.057
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.057
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.056
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.056
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.056
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.056
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.056
|
|
|
|
chondroblast differentiation
|
GO:0060591 |
2 |
0.056
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.056
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.056
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.055
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.055
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.054
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.054
|
Mouse |
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.054
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.053
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.052
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.052
|
|
|
|
collagen biosynthetic process
|
GO:0032964 |
7 |
0.052
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.051
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.051
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.051
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.051
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.051
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.050
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.050
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.050
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.050
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.050
|
|
|
|
cellular response to retinoic acid
|
GO:0071300 |
25 |
0.049
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.049
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.049
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.049
|
|
|
|
glomerular basement membrane development
|
GO:0032836 |
8 |
0.049
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.049
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.049
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.049
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.048
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.048
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.048
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.048
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.048
|
Zebrafish Mouse |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.048
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.047
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.047
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.047
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.047
|
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.047
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.047
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.046
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.046
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.046
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.045
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.045
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.045
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.045
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.045
|
|
|
|
membrane invagination
|
GO:0010324 |
17 |
0.045
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.045
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.044
|
|
|
|
limb bud formation
|
GO:0060174 |
10 |
0.044
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.044
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.044
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.044
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.044
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.043
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.043
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.043
|
|
|
|
negative regulation of toll signaling pathway
|
GO:0045751 |
1 |
0.043
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.043
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.042
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.042
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.042
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.042
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.042
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.042
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.041
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.041
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.041
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.041
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.041
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.040
|
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
14 |
0.040
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.040
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.040
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.040
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.040
|
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.039
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.039
|
|
|
|
positive regulation of rho protein signal transduction
|
GO:0035025 |
7 |
0.039
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.039
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.039
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.039
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.038
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.038
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.038
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.037
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.037
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.037
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.037
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.037
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.036
|
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.036
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.036
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.036
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.036
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.036
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.036
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.036
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.036
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.035
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.035
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.035
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.035
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.034
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.034
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.034
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.034
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.034
|
|
|
|
positive regulation of integrin mediated signaling pathway
|
GO:2001046 |
5 |
0.034
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.034
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.033
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.033
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.033
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.033
|
|
|
|
peptide cross linking
|
GO:0018149 |
10 |
0.033
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.033
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.033
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.033
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.033
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.033
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
40 |
0.033
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.033
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.032
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.032
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.032
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.032
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.032
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.032
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.031
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.031
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.031
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.031
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.031
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.031
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.030
|
Mouse |
|
|
female gonad development
|
GO:0008585 |
71 |
0.030
|
Mouse |
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.030
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.030
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.030
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.030
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.030
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.030
|
|
|
|
protein folding
|
GO:0006457 |
28 |
0.030
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.030
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.029
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.029
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.029
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.029
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.029
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.029
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.029
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.029
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.029
|
|
|
|
negative regulation of neuron migration
|
GO:2001223 |
6 |
0.029
|
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
2 |
0.029
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.029
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.029
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.029
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.029
|
|
|
|
membrane raft assembly
|
GO:0001765 |
3 |
0.028
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.028
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.028
|
|
|
|
positive regulation of receptor biosynthetic process
|
GO:0010870 |
1 |
0.028
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.028
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.028
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.028
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.028
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.028
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.028
|
|
|
|
protein localization to cell surface
|
GO:0034394 |
10 |
0.028
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.028
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.028
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.028
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.028
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.027
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.027
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.027
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.027
|
|
|
|
vegf activated neuropilin signaling pathway involved in axon guidance
|
GO:1902378 |
1 |
0.027
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.027
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.027
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.027
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.027
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.027
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.027
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.027
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.027
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.027
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.027
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.026
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.026
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.026
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.026
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.026
|
|
|
|
positive regulation of endothelial cell migration
|
GO:0010595 |
12 |
0.026
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.026
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.026
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.026
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.026
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.025
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.025
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.025
|
|
|
|
negative regulation of tooth mineralization
|
GO:0070171 |
1 |
0.025
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.025
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.025
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.025
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.025
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.025
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.025
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.025
|
|
|
|
locomotory exploration behavior
|
GO:0035641 |
10 |
0.025
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.024
|
|
|
|
response to catecholamine
|
GO:0071869 |
4 |
0.024
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.024
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.024
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.024
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.024
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.024
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.024
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.024
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.024
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.023
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.023
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.023
|
Zebrafish Mouse |
|
|
receptor biosynthetic process
|
GO:0032800 |
3 |
0.023
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.023
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.023
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.023
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.023
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.023
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.023
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.023
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.023
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.023
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.022
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.022
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.022
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.022
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.022
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.022
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.022
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.022
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.022
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.022
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.022
|
|
|
|
positive regulation of acute inflammatory response to non antigenic stimulus
|
GO:0002879 |
2 |
0.022
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.022
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.021
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.021
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.021
|
|
|
|
aldosterone metabolic process
|
GO:0032341 |
2 |
0.021
|
|
|
|
otolith morphogenesis
|
GO:0032474 |
3 |
0.021
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.021
|
|